A retired cardiologist and former FDA official documents his personal effort to find a Parkinson's treatment, mixing commentary on recent trial results with his own research history and operational updates on drug development. Readers get a firsthand, detailed view of how a non-specialist approaches PD science and what regulatory and safety steps a potential drug must clear.
Get the best new newsletters in your inbox
One short email a week with hand-picked newsletters from the index. Free, no spam, unsubscribe anytime.